Follow-up of the immune response ten years after intradermal or subcutaneous yellow fever vaccination

Follow-up of the immune response ten years after intradermal or subcutaneous yellow fever vaccination - Yellow fever vaccination follow-up after 10 years

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON43303

Enrollment

155

Registered

2017-02-15

Start date

2017-03-13

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

immune response to yellow fever vaccination

Interventions

immune response

intradermal

vaccination

yellow fever

Eligibility

Age

18 Years to 64 Years

Inclusion criteria

Inclusion criteria: Participants of the yellow fever vaccination study performed 10 years ago

Exclusion criteria

Exclusion criteria: standard yellow fever vaccination after participating in the trial ten years ago

Design outcomes

Primary

Measure	Time frame
protective immune response, measured in neutralizing antibodies, 10 years after yellow fever vaccination (i.d. administration compared to s.c.)	—

Secondary

Measure	Time frame
none	—

Countries

The Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)